Bened Life Announces Launch of Neuralli® Cognition+
New formulation provides clinically studied support for cognition, short-term memory, and muscle strength in adults 50+.*
Short-term memory plays a central role in day-to-day functioning — from recalling names and details to managing instructions and tasks. Neuralli® Cognition+ offers a scientifically backed approach to supporting short-term memory in adults aged 50 and older and daily cognitive function and quality of life as you age.*
Neuralli® Cognition+ contains two clinically studied probiotic strains, Bifidobacterium breve MCC1274 and Lacticaseibacillus paracasei PS23™, available exclusively from
Seven peer-reviewed clinical studies on the individual strains highlight their potential contribution to healthy aging, demonstrating measurable improvements in short-term memory performance and muscle strength. The research underscores
"Neuralli® Cognition+ is an important milestone in our mission to advance gut-brain science into accessible, evidence-informed products," said
Neuralli® Cognition+ complements
- Neuralli® MP, a probiotic medical food formulated for individuals with neurological conditions
- Neuralli® Mood, designed to support a calm mood and a healthy stress response.*
Pre-sale of Neuralli Cognition+ is live at BenedLife.com, with shipments expected
About
For media contacts, email [email protected]
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
View original content:https://www.prnewswire.com/news-releases/bened-life-announces-launch-of-neuralli-cognition-302629538.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CB&I secures new Côte d'Ivoire operations and maintenance contract
- Havas Reports the Progress of Transactions Under Its Current Share Buyback Program
- First German GHG trade initiated on Argus Open Markets platform
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share